Skip to content
Insider tapeFilings through Fri, Oct 2
Watchlist

Michael E Prevoznik

General Counsel at Quest Diagnostics Inc (DGX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.6M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 31SEC DGXQuest Diagnostics Inc Sell Plan 16,010 $242.88 $3.9M -4.4%
Aug 31SEC DGXQuest Diagnostics Inc Sell Plan 6,237 $243.63 $1.5M -4.7%
Aug 31SEC DGXQuest Diagnostics Inc Sell Plan 430 $244.51 $105K -5.0%
Mar 6SEC DGXQuest Diagnostics Inc Sell Plan 3,878 $206.21 $800K +12.6%
Mar 4SEC DGXQuest Diagnostics Inc Sell Plan 526 $207.73 $109K +11.8%
Feb 20SEC DGXQuest Diagnostics Inc Sell Plan 1,111 $204.83 $228K +13.4%
  • Sell

    General Counsel Michael E Prevoznik sold $3.9M of DGX at $242.88 — cuts the stake by 27%; pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Michael E Prevoznik sold $1.5M of DGX at $243.63 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Michael E Prevoznik sold $105K of DGX at $244.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Michael E Prevoznik sold $800K of DGX at $206.21 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Michael E Prevoznik sold $109K of DGX at $207.73 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Michael E Prevoznik sold $228K of DGX at $204.83 — pre-scheduled 10b5-1 plan sale.